Directorate Change

2 July 2015

Phorm Corporation Limited

("Phorm" or the "Company")

Directorate Change

Phorm (AIM: PHRM), a leading internet personalisation technology company, is pleased to announce the appointment of Mr Michael Alkin as a Non-Executive Director of the Company with immediate effect.

Mr Alkin is currently a Portfolio Manager of the Tullamore Fund at Hilton Capital Management, LLC. Prior to joining Hilton Capital, Mr Alkin worked for 17 years in the hedge fund industry, most recently as a Portfolio Manager at Kellner Capital, having previously spent 7 years at Knott Partners LP as a Senior Partner of its US$1.5 billion equity hedge fund. Prior Analyst and Portfolio Manager positions include Walker Smith Capital, Blackbird Capital Partners (of which he was co-founder), Gilder Gagnon Howe, RH Capital, Scout Capital, Zweig Dimenna and Windsor Partners. Mr Alkin is a graduate of Dowling College, Long Island, holding a B.B.A. in Accounting.

Kent Ertugrul, Chairman and CEO of Phorm, commented:

"We are delighted to welcome Michael to the Phorm Board. His valuable experience of international capital markets and analytical skillset will assist us with the group's future growth and development."

Additional information on Mr Michael Alkin

The following additional information is provided in accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies:

Michael Craig Alkin (aged 50)

Mr Alkin is currently interested in 7,555,813 ordinary shares of nil par value each in the capital of Phorm, representing approximately 0.90 per cent. of the Company's existing issued share capital.

There is no other information that is required to be disclosed pursuant to paragraph (g) of Schedule Two to the AIM Rules for Companies.

-Ends-

For further information please contact: Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 (0) 203 397 6001

UK Investors

Mirabaud Securities LLP (Broker) +44 20 7321 2508

Jason Woollard Peter Krens

Strand Hanson Limited (Nominated Adviser) +44 20 7409 3494

James Harris Matthew Chandler James Dance

US Investors

Lippert/Heilshorn and Associates (Investor Relations) +1 212 838 3777

John Heilshorn

About Phorm

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's industry leading technology enables its Internet Service Provider ("ISP") partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

For more information, please visit: www.phorm.com